Abstract:Virus like particles (VLPs) have been well recognized as one of the most important vaccine platforms due to their structural similarity to natural viruses to induce effective humoral and cellular immune responses. Nevertheless, lack of viral nucleic acids in VLPs usually leads the vaccine candidates less efficient in provoking innate immune against viral infection. Here, we constructed a biomimetic dual antigen hybrid influenza nanovaccines THM-HA@Mn with robust immunogenicity via in situ synthesizing a stimulator of interferon genes (STING) agonist Mn 3 O 4 inside the cavity of a recombinant Hepatitis B core antigen VLP (HBc VLP) having fused SpyTag and influenza M2e antigen peptides (Tag-HBc-M2e, THM for short), followed by conjugating a recombinant hemagglutinin (rHA) antigen on the surface of the nanoparticles through SpyTag/SpyCatcher ligating. Such inside Mn 3 O 4 immunostimulator-outside rHA antigen design, together with the chimeric M2e antigen on the HBc skeleton, enabled the synthesized hybrid nanovaccines THM-HA@Mn to well imitate the spatial distribution of M2e/HA antigens and immunostimulant in natural influenza virus. In vitro cellular experiments indicated that compared with the THM-HA antigen without Mn 3 O 4 and a mixture vaccine consisting of THM-HA + MnOx, the THM-HA@Mn hybrid nanovaccines showed the highest efficacies in dendritic cells uptake and in promoting BMDC maturation, as well as inducing expression of TNF-α and type I interferon IFN-β. The THM-HA@Mn also displayed the most sustained antigen release at the injection site, the highest efficacies in promoting the DC maturation in lymph nodes and germinal center B cells activation in the spleen of the immunized mice. The co-delivery of immunostimulant and antigens enabled the THM-HA@Mn nanovaccines to induce the highest systemic antigen-specific antibody responses and cellular immunogenicity in mice. Together with the excellent colloid dispersion stability, low cytotoxicity, as well as good biosafety, the synthetic hybrid nanovaccines presented in this study offers a promising strategy to design VLP-based vaccine with robust natural and adaptive immunogenicity against emerging viral pathogens.

Guanidinothiosialoside-Human Serum Albumin Conjugate Mimics mucin Barrier to Restrict Influenza Infection

Amide-sialoside Protein Conjugates As Neomucin Bioshields Prevent Influenza Virus Infection.

A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity

Preparation of Eicosavalent Triazolylsialoside-Conjugated Human Serum Albumin As a Dual Hemagglutinin/neuraminidase Inhibitor and Virion Adsorbent for the Prevention of Influenza Infection

Multivalent Oleanolic Acid Human Serum Albumin Conjugate As Nonglycosylated Neomucin for Influenza Virus Capture and Entry Inhibition.

Assembly of Poly(ethylene Glycol)ylated Oleanolic Acid on a Linear Polymer As a Pseudomucin for Influenza Virus Inhibition and Adsorption.

Multivalent Neuraminidase Hydrolysis Resistant Triazole-Sialoside Protein Conjugates As Influenza-Adsorbents

Preparation of a Thioxoimidazolidin-Linked Sialoside BSA Conjugate for the Inhibition of Influenza Virus

Multivalent S-sialoside Protein Conjugates Block Influenza Hemagglutinin and Neuraminidase.

Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles

Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus

Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase

Structural Determinants of Mucins in Influenza Virus Inhibition: The Synergistic Role of Sialylated Glycans and Molecular Size

Sialylated Immunoglobulin G Can Neutralize Influenza Virus Infection Through Receptor Mimicry

Thiolated Chitosan Encapsulation Constituted Mucoadhesive Nanovaccine Confers Broad Protection Against Divergent Influenza A Viruses

Synthesis and In Vitro Anti-Influenza Virus Evaluation of Novel Sialic Acid (C-5 and C-9)-Pentacyclic Triterpene Derivatives

Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles

Glycopolymer with Sulfated Fucose and 6'-Sialyllactose as a Dual-Targeted Inhibitor on Resistant Influenza A Virus Strains

Synthesis and immunological evaluation of the unnatural β-linked mucin-1 Thomsen-Friedenreich conjugate

In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines

Trivalent oleanolic acid-glucose conjugates: Synthesis and efficacy against Influenza A virus